Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?

被引：43

作者：

Mangen, Marie-Josee J. ^{[1
,2
]}

van Duynhoven, Yvonne T. H. P. ^{[2
]}

Vennema, Harry ^{[2
]}

van Pelt, Wilfrid ^{[2
]}

Havelaar, Arie H. ^{[2
,3
]}

de Melker, Hester E. ^{[2
]}

机构：

[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands

[2] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands

[3] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands

来源：

VACCINE | 2010年 / 28卷 / 14期

关键词：

Rotavirus vaccination; National immunization program; Cost-effectiveness; RISK-FACTORS; DISEASE BURDEN; GASTROENTERITIS; ENGLAND; HOSPITALIZATIONS; NETHERLANDS; INFECTIONS; EFFICACY; INFANTS; CAMPYLOBACTER;

D O I：

10.1016/j.vaccine.2010.01.014

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This study assessed whether the inclusion of two rotavirus (RV) vaccines in the Dutch national immunization programme is cost-effective. Costs and outcomes in unvaccinated and vaccinated populations are compared for a time period of 20 years. In the baseline, assuming competitive market forces in relation to vaccine costs, Rotarix (R) is more cost-effective than RotaTeq (R), resulting in a cost-utility ratio (CUR) of (sic) 53,000 per DALY (third payer perspective) and (sic) 49,000 per DALY (societal perspective), but both considered as being not cost-effective. Vaccine-related costs, annual epidemic-size, and indirect protection are the major factors that determine cost-effectiveness of RV vaccination. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：2624 / 2635

页数：12

共 50 条

[31] Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018)
Hemming-Harlo, Maria
Gylling, Annette
Herse, Fredrik
Haavisto, Ira
Nuutinen, Mikko
Pasternack, Michael
Kanibir, M. Nabi
Hartwig, Susanne
Carias, Cristina
VACCINE, 2022, 40 (29) : 3942 - 3947
[32] IS ADDING HCV SCREENING TO THE ANTENATAL NATIONAL SCREENING PROGRAM IN AMSTERDAM, THE NETHERLANDS COST-EFFECTIVE?
Urbanus, A.
van Keep, M.
Matser, A.
Rozenbaum, M.
Weegink, C.
van den Hoek, A.
Prins, M.
Postma, M.
JOURNAL OF HEPATOLOGY, 2013, 58 : S22 - S22
[33] Developing a cost-effective brand loyalty program
Wansink, B
JOURNAL OF ADVERTISING RESEARCH, 2003, 43 (03) : 301 - 309
[34] DEVELOPING A COST-EFFECTIVE CLINICAL PRECEPTORSHIP PROGRAM
MOONEY, VA
DIVER, B
SCHNACKEL, AA
JOURNAL OF NURSING ADMINISTRATION, 1988, 18 (01): : 31 - 36
[35] COST-EFFECTIVE PAINTING PROGRAM FOR A NEW PLANT
LICHTENSTEIN, J
MATERIALS PERFORMANCE, 1983, 22 (10) : 13 - 13
[36] UOSAT - A COST-EFFECTIVE SPACECRAFT ENGINEERING PROGRAM
GIBSON, R
JOURNAL OF THE INSTITUTION OF ELECTRONIC AND RADIO ENGINEERS, 1987, 57 (05): : S97 - S98
[37] HPV vaccination in China needs to be more cost-effective
Yin, Yue
LANCET, 2017, 390 (10104): : 1735 - 1736
[38] Global human papillomavirus vaccination: can it be cost-effective?
Crosbie, E. J.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (02) : 125 - 128
[39] Validation of parental reports of rotavirus vaccination of their children compared to the national immunization registry
Bercovich, Shayel
Anis, Emilia
Kassem, Eias
Rubinstein, Uri
Ephros, Moshe
Cohen, Dani
Muhsen, Khitam
VACCINE, 2019, 37 (21) : 2791 - 2796
[40] Is herpes zoster vaccination likely to be cost-effective in Canada?
Alexander D. Peden
Stephenson B. Strobel
Evelyn L. Forget
Canadian Journal of Public Health, 2014, 105 : e287 - e295

← 1 2 3 4 5 →